热门资讯> 正文
Theralase开始200万加元的非经纪私募
2025-12-13 06:09
- Theralase Technologies Inc (TLTFF) has commenced a non-brokered private placement of units of the company to raise up to C$ 2M.
- In the offering, each unit is priced at C$ 0.17 and consists of one common share of the Company and one Common Share purchase warrant. Each Warrant will entitle the holder thereof to purchase one Common Share of the Company for a period of 60 months following the Closing Date of the Offering at an exercise price of C$0.21 per Warrant Share.
- The Company plans to use the proceeds of the Offering to further the Phase II Non-Muscle Invasive Bladder Cancer ("NMIBC") clinical study currently underway and for working capital needs.
- Source: Press Release
More on Theralase Technologies Inc., TMX Group Limited
- TMX Group Limited (X:CA) Q3 2025 Earnings Call Transcript
- North Peak Resources appoints Jim O'Neill as CFO
- Metal Energy to raise C$9.3M funding; Centerra Gold to become strategic investor
- Seeking Alpha’s Quant Rating on Theralase Technologies Inc.
- Historical earnings data for Theralase Technologies Inc.
推荐文章
华盛早报 | 1月再降息？瑞银称市场低估其概率；特斯拉大涨超3%创年内新高
华盛早报 | 美联储主席人选生变？除了哈塞特，特朗普也支持沃什；AI泡沫论重燃”？甲骨文大跌后紧急回应
新股申购 | 诺比侃、翰思艾泰-B、轻松健康三只新股今起招股！
新兴市场套利狂潮未止！华尔街看好2026年高收益货币前景
详解美联储意外“扩表”，影响几何？
港股周报 | 定调2026！中央经济工作会议机构最新解读来了；中兴通讯遭遇重磅利空后，拟至多回购12亿元股份
12月13日外盘头条：特朗普倾向由沃什或哈塞特领导美联储 博通暴跌 甲骨文推迟OpenAI部分数据中心工期
一周财经日历 | 聚焦数据！11月非农就业报告和CPI年率接踵而来；传日本央行下周加息“板上钉钉”；美光财报出炉
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
